MedPath

The Heart Health Study - increasing cardiovascular risk assessment in first degree relatives of patients with premature heart disease by provision of written and verbal advice

Not Applicable
Completed
Conditions
Cardiovascular - Coronary heart disease
prevention of cardiovascular disease
Public Health - Health promotion/education
Registration Number
ACTRN12613000557730
Lead Sponsor
The University of Adelaide
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
140
Inclusion Criteria

Patients: hospitalised with their first premature ischaemic heart disease (PIHD) event, with the event determined as occurring before age 55 in men, and before age 65 in women. An IHD event is defined as any one of the following: non-ST-segment elevation myocardial infarction (NSTEMI) and ST-segment elevation myocardial infarction (STEMI), unstable angina and coronary revascularisation (coronary artery bypass grafting, coronary angioplasty with or without coronary stenting).

Relatives: siblings and children (18 years and over) of the patient, without diagnosed IHD, and residing in Australia, are eligible for this study.

Exclusion Criteria

Excluding: patients who are terminally ill, experiencing dementia and/or other significant cognitive impairment, unable to speak English, illiterate, and any condition that their treating doctor believes warrants intensive family follow-up and intervention.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Proportion of relatives (of patients with premature ischaemic heart disease (PIHD)) attending their GP for cardiovascular risk assessment [6 months after patients’ PIHD event and randomisation]
Secondary Outcome Measures
NameTimeMethod
Proportion of relatives (of patients with PIHD) who responded to the invitation to receive verbal advice from either a GP or nurse depending on participant preference?[6 months after patients’ PIHD event and randomisation];Was attendance for risk assessment more likely in the group receiving verbal advice? [6 months after patients’ IHD event and randomisation];How many risk factors have been identified by their GP since their relative’s PIHD event and are being actively managed (by dietary modification, lifestyle modification or medication) at 6 months in both groups? <br><br>For the intervention group: risk factors identified at the cardiovascular risk assessment appointment with GP since relative’s PIHD event 6 months ago. <br><br>For the standard care group: risk factors identified at any appointment with GP since relative’s PIHD event 6 months ago<br>[6 months after patients’ PIHD event and randomisation]
© Copyright 2025. All Rights Reserved by MedPath